A Phase 4 interventional study of Ropivacaine and Sham Comparator in Mouth Abnormalities, Cleft Palate and Birth Defect, sponsored by University of Florida. Active, not recruiting at 1 site in United States. Open to participants aged 3 Months to 5 Years. Per ClinicalTrials.gov, last updated 2026-07-21.
Sponsored by University of Florida · Phase 4, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 31 studies in Cleft Palate with a site in United States — 9 open to participants now, 11 under way, 1 of them phase 3. Cleft Palate · United States.
Among the 31 studies in Cleft Palate with a site in United States, this one is the 14th largest by planned enrollment of the 22 interventional ones that give a count, is one of 2 that started in 2018, is one of 2 in phase 4, reaches primary completion later than 4 of the 10 other live ones, and was the 20th registered.
123 studies on the registry are indexed under Cleft Palate; 35 are open to participants now.
Browse Cleft Palate studies →9 of the 31 studies in Cleft Palate with a site in United States are open now. Recruiting first, the newest first:
Phoenix Children's Hospital · Sites in United States
Ages 0 mo–12 mo
Duke University · Sites in United States
Ages 6 mo–4 yrs
Noel Jabbour · Sites in United States
Ages 5–17
Medical University of South Carolina · Sites in United States
Ages 6–18
Kerry O'Rourke · Sites in United States
Ages 6+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 21 Cleft Palate studies recruiting now, 3 (14%) set no upper age limit and 18 (86%) stop at 75 or younger; 20 take children under 18; 2 take healthy volunteers.
This study: 3 Months to 5 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
31 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 5 · Phase 3 2 · Phase 4 2
First in 1996; this study’s year is marked. 2 started in 2018.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 40 is close to the median of 44 across 77 interventional studies indexed under Cleft Palate.
Median enrollment 47 across the 22 interventional studies, 130 across the 9 observational. Of the 18 that completed or were terminated, 5 (28%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 31 has an industry lead sponsor. The 10 most frequent:
University of Florida is the lead sponsor of 1,290 studies on the registry; 202 are open to participants now.
Of its 181 completed or terminated interventional studies of FDA-regulated products, 143 (79%) have results posted.
University of Florida has 3 studies filed under Cleft Palate — fewer than ten, so there is no comparison to draw.
5 of the studies in Cleft Palate with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07219901Old Dominion UniversityEarly Intervention in Infants With Unrepaired Cleft Palate: Language, Palatal Function, and Articulation. | 2026-12-31 |
| NCT06420336Medical University of South CarolinaQL vs LAI for Palatoplasty | 2027-01-01 |
| NCT05492266Noel JabbourExpiratory Muscle Strength Training for Hypernasal Speech in Children | 2027-05 |
| NCT03632044University of FloridaEvaluation of Trigeminal Nerve Blockade | 2027-05-31 |
| NCT06962306Duke UniversityOptimizing Perioperative Analgesia to Lower Pain Following Cleft Palate Surgery | 2027-06-04 |
Add all 5 to your calendar (.ics) → With an account.
Among the 31 studies in Cleft Palate with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Cleft palate repair requires high doses of opioids for pain control postop. An alternative approach is placement of nerve blocks in the pterygopalatine fossa bilaterally, blocking the maxillary nerve \& covering the entire midface. Application of bilateral suprazygomatic maxillary nerve blockade of the infraorbital nerve may provide effective analgesia for cleft lip repair, improving time to oral intake, pain control and time to hospital discharge.
Cleft palate is a common congenital anomaly for which surgical repair is indicated during early childhood. The surgical repair of cleft palate is very painful, and generally requires high doses of opioids for adequate pain control, placing children at risk for post-operative respiratory depression and airway obstruction. An alternative approach to post-operative analgesia for cleft palate repair is the placement of nerve blocks in the pterygopalatine fossa bilaterally, blocking the maxillary nerve and covering the entire mid-face. This randomized, double-blinded study will investigate the utility of maxillary nerve blockade in controlling post-operative pain, decreasing opioid requirements, improving post-operative oral food and drink intake, and decreasing hospital length-of-stay after cleft palate repair.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
A single injection into the pterygopalatine fossa bilaterally of 0.2% ropivacaine at a dose of 0.15 mL/kg (block) after the induction of general anesthesia.
Drug: Ropivacaine
Subcutaneous placement of a 25 Gauge needle as a sham comparator after the induction of general anesthesia. Nothing will be injected.
Other: Sham Comparator
A single injection into the pterygopalatine fossa bilaterally of 0.2% ropivacaine at a dose of 0.15 mL/kg (block) after the induction of general anesthesia
Also known as: Naropin
The subcutaneous placement of a 25 Gauge needle as a sham control after the induction of general anesthesia. Nothing will be injected.
Also known as: Control
Change in time to oral intake following palatoplasty for cleft palate
Application of bilateral suprazygomatic maxillary nerve blockade of the infraorbital nerve to provide effective analgesia for cleft lip repair, improving time to oral intake after surgery.
Time frame: Change from baseline (post-op) and through study completion, an average of 96 hours.
Change in amount of opioids following palatoplasty for cleft palate
Application of bilateral suprazygomatic maxillary nerve blockade of the infraorbital nerve to provide effective analgesia for cleft lip repair, improving pain control after surgery.
Time frame: Change from baseline (post-op) and through study completion, an average of 96 hours.
Change in length of hospitalization following palatoplasty for cleft palate
Application of bilateral suprazygomatic maxillary nerve blockade of the infraorbital nerve to provide effective analgesia for cleft lip repair, improving time to hospital discharge after surgery.
Time frame: Change from baseline (post-op) and through study completion, an average of 96 hours.
Started Nov 2018 (actual). Primary completion is estimated for May 2027, 102 months after the start.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Ropivacaine